Racaemic pantoprazole - Takeda

Drug Profile

Racaemic pantoprazole - Takeda

Alternative Names: Anagastra; B-8610-23; BY-1023; Controloc; DZ-2352A; Eupantol; Inipomp; Pangest; Pantecta; Pantoloc; Pantop; Pantopan; Pantozol; Peptazol; Protium; Protonix; Rifun; SKF 96022; Somac; Tecta; Tecta Control; Ulcotenal; ZacPac; Zurcal

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nycomed
  • Developer Takeda Pharmaceuticals International GmbH
  • Class 2 pyridinylmethylsulfinylbenzimidazoles; Antiulcers; Gastric antisecretories; Small molecules
  • Mechanism of Action Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Duodenal ulcer; Erosive oesophagitis; Gastric ulcer; Gastritis; Gastro-oesophageal reflux; Heartburn; Helicobacter infections; Peptic ulcer; Zollinger-Ellison syndrome
  • No development reported Pancreatitis

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Pancreatitis in Germany
  • 15 Mar 2016 Biomarkers information updated
  • 12 Dec 2013 Launched prior to December 2013 for Gastro-oesophageal reflux in Brazil, Mexico and the Ukraine (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top